05May
[Webinar] Diagnostics, Antibody Testing and Vaccines: Global Outlook on Life Sciences COVID-19 Advances and Evolving Deal Trends - May 7th, 11:00 am - 12:15 pm EDT
Across the US and EU, life sciences companies are pushing diagnostics, antibody testing, vaccines and other efforts forward to flatten the Coronavirus (COVID-19) curve. Our multidisciplinary cross-border life sciences team will examine the current...
By:
McDermott Will & Emery
Related
BakerHostetler will present data regarding Texas’ robust M&A market each quarter, with useful compa...
Read More >
While the United States and California legal worlds remain (understandably) focused on issues arisin...
Read More >
If you watch the news, you may have heard that the requirement known as the “individual mandate” u...
Read More >
Surface transportation has been a topic of federal policy consideration in recent weeks. The U.S. Ho...
Read More >
The U.S. District Court for the Eastern District of California heard oral argument on January 10, 20...
Read More >
Your company has just made its largest acquisition ever and your CEO says they want you to have a co...
Read More >